PMGC HOLDINGS INC. Investing Cash Flow
PMGC HOLDINGS INC. (ELAB) reported Investing Cash Flow of -$6.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$3.68M, a 1972.04% decline year-over-year.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$2.48M.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$548.64K.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.20M.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2025 was -$2.77M.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2024 was -$610.56K.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2023 was -$11.19K.
- PMGC HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2022 was -$32.03K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.17M 10-Q · filed 2026-08-14 | -$6.72M derived: sum of 3 quarters · filed 2026-08-14 | -$8.92M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$2.48M 10-Q · filed 2026-05-15 | -$3.03M derived: sum of 2 quarters · filed 2026-05-15 | -$5.23M derived: sum of 3 quarters · filed 2026-05-15 | -$5.03M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$548.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.75M derived: sum of 2 quarters · filed 2026-03-30 | -$2.55M derived: sum of 3 quarters · filed 2026-08-14 | -$2.77M 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.00M derived: sum of 2 quarters · filed 2026-08-14 | -$2.22M 10-Q · filed 2025-11-14 | -$2.66M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $196.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$18.48K 10-Q · filed 2026-08-14 | -$457.56K derived: sum of 3 quarters · filed 2026-08-14 | -$507.56K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$215.32K 10-Q · filed 2026-05-15 | -$654.40K derived: sum of 2 quarters · filed 2026-05-15 | -$704.40K derived: sum of 3 quarters · filed 2026-05-15 | -$766.72K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$439.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$489.08K derived: sum of 2 quarters · filed 2026-03-30 | -$551.40K derived: sum of 3 quarters · filed 2026-03-30 | -$610.56K 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$112.32K derived: sum of 2 quarters · filed 2025-11-14 | -$171.48K 10-Q · filed 2025-11-14 | -$171.48K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$62.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$121.48K 10-Q · filed 2025-08-13 | -$121.48K derived: sum of 3 quarters · filed 2025-08-13 | -$121.48K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$59.16K 10-Q · filed 2025-05-14 | -$59.16K derived: sum of 2 quarters · filed 2025-05-14 | -$59.16K derived: sum of 3 quarters · filed 2025-05-14 | -$59.16K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | -$11.19K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$11.19K 10-Q · filed 2024-11-14 | -$11.19M 10-Q · filed 2023-12-11 | $33.38M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$11.19K 10-Q · filed 2024-08-14 | $33.38M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$11.19K 10-Q · filed 2024-05-15 | $33.38M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $33.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$32.03K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$33.43M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |